Onconetix (ONCO) Change in Inventory (2023 - 2026)
Onconetix (ONCO) posted quarterly Change in Inventory of -$11654.0 for Q1 2026, down 112.8% year-over-year from $91019.0 in Q1 2025, and down 2422.51% quarter-over-quarter from -$462.0 in Q4 2025.
Onconetix (ONCO) Change in Inventory (2023 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Change in Inventory for 4 consecutive years, with -$11654.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 112.8% year-over-year to -$11654.0; the TTM figure through Mar 2026 stood at -$28953.0 (down 124.89% YoY), while the FY2025 annual figure was $73720.0, up 18.38% from the prior year.
- Change in Inventory retreated to -$11654.0 in Q1 2026 per ONCO's latest filing, from -$462.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $247372.0 in Q3 2023 and bottomed at -$50829.0 in Q4 2024.
- Historically, Change in Inventory has averaged $35297.0 across 4 years, with a median of $1417.0 in 2025.
- Annual changes were most pronounced in 2024 — Change in Inventory tumbled 407.01% — and 2025, when it surged 146.17%.
- Onconetix's Change in Inventory stood at $16556.0 in 2023, then sank by 407.01% to -$50829.0 in 2024, then jumped by 99.09% to -$462.0 in 2025, then slumped by 2422.51% to -$11654.0 in 2026.
- Business Quant data shows ONCO's Change in Inventory at -$11654.0 in Q1 2026, -$462.0 in Q4 2025, and $1417.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 76,247.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76,247.00 |
| Jun 30, 2026 | 76,247.00 |
| Mar 31, 2026 | -11,654.00 |
| Mar 31, 2026 | -11,654.00 |
| Dec 31, 2025 | -462.00 |
| Dec 31, 2025 | -462.00 |
| Sep 30, 2025 | 1,417.00 |
| Sep 30, 2025 | 1,417.00 |
| Jun 30, 2025 | -18,254.00 |
| Jun 30, 2025 | -18,254.00 |
| Mar 31, 2025 | 91,019.00 |
| Mar 31, 2025 | 91,019.00 |
| Dec 31, 2024 | -50,829.00 |
| Dec 31, 2024 | -50,829.00 |
| Sep 30, 2024 | -45,993.00 |
| Sep 30, 2024 | -45,993.00 |
| Jun 30, 2024 | 122,121.00 |
| Jun 30, 2024 | 122,121.00 |
| Mar 31, 2024 | 36,974.00 |
| Mar 31, 2024 | 36,974.00 |